| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/03/1997 | WO1997023614A1 Osteoprotegerin |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023602A1 Improved immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
| 07/03/1997 | WO1997023598A2 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 07/03/1997 | WO1997023509A1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023231A1 Novel use of compositions containing mother-of-pearl |
| 07/03/1997 | WO1997023129A1 Model transgenic animal for interleukin-1 relevant diseases |
| 07/03/1997 | WO1997018232A3 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae |
| 07/03/1997 | CA2240847A1 Process for propagation and/or selection of plant material |
| 07/03/1997 | CA2240739A1 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | CA2214095A1 Novel use of compositions containing mother-of-pearl |
| 07/02/1997 | EP0781849A1 Tissue-specific promoter |
| 07/02/1997 | EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production |
| 07/02/1997 | EP0781844A1 Gene participating in apoptosis |
| 07/02/1997 | EP0781347A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
| 07/02/1997 | EP0781343A1 Retroviral vector hybrids and the use thereof for gene transfer |
| 07/02/1997 | EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/02/1997 | EP0781338A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
| 07/02/1997 | EP0781336A1 A human map kinase homolog |
| 07/02/1997 | EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 07/02/1997 | EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 07/02/1997 | EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 07/02/1997 | EP0781095A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 07/02/1997 | EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a |
| 07/02/1997 | EP0739418B1 Methods of identifying lymphocytes with mutator phenotypes |
| 07/02/1997 | EP0702720A4 Method for defined deletions of dna |
| 07/02/1997 | EP0689552A4 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 07/02/1997 | EP0592692B1 Fed batch process for protein secreting cells |
| 07/02/1997 | EP0575350A4 Method for culturing and transforming human stem cell-containing compositions |
| 07/02/1997 | CN1153528A Pantropic neurotrophic factors |
| 07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| 07/01/1997 | US5643966 Antitumor agents |
| 07/01/1997 | US5643789 Innoculation of cells with bioreactive glass for bone tissue culture |
| 07/01/1997 | US5643788 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 07/01/1997 | US5643787 Adenocarcinoma cell basement membrane composition |
| 07/01/1997 | US5643786 Method for isolating dendritic cells |
| 07/01/1997 | US5643785 Polynucleotides encoding AMPA-binding human GluR4 receptors |
| 07/01/1997 | US5643781 DNA encoding protocadherin-42 |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | US5643774 Dna molecules with polypeptides formed by biosynthesis |
| 07/01/1997 | US5643773 Preparation of elongated seamless capsules containing a coaxial rod and biological material |
| 07/01/1997 | US5643759 Hybridoma cell lines |
| 07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
| 07/01/1997 | US5643746 Human epidermal gene promoter |
| 07/01/1997 | US5643741 Mixing cells with antibodies and binding |
| 07/01/1997 | US5643736 Hybridomas and detection of osteogenic cell subsets |
| 07/01/1997 | US5643735 Anti-thymosin α1 monoclonal antibody-producing hybridoma |
| 07/01/1997 | US5643726 Integral membrane glycoproteins, genes and promoters |
| 07/01/1997 | US5643714 Method and assay for HTLV |
| 07/01/1997 | US5643594 Forming microcapsules of biological tissue coated with crosslinked alginates, projecting beads from a rotating cup and collecting them in an independently rotating container of gelling solution |
| 07/01/1997 | US5643572 Monoclonal antibody to urushiol |
| 07/01/1997 | US5643569 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells |
| 07/01/1997 | US5643561 Coating composition for culturing animal cells and method for culturing of the cells in serum-free condition |
| 07/01/1997 | US5643551 Antitumor agents for human cells |
| 06/26/1997 | WO1997022722A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | WO1997022716A1 Process for activating a kinase |
| 06/26/1997 | WO1997022711A1 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
| 06/26/1997 | WO1997022709A1 Host adaptation of retroviral vectors |
| 06/26/1997 | WO1997022708A1 Primate cluster-forming embryonic hematopoietic stem cells |
| 06/26/1997 | WO1997022707A1 An expression system for anaerobic gene expression in higher plants |
| 06/26/1997 | WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 06/26/1997 | WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
| 06/26/1997 | WO1997022696A1 Utrophin gene expression |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022689A1 Chromosome 13-linked breast cancer susceptibility gene |
| 06/26/1997 | WO1997022623A1 Osteo antiviral protein |
| 06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
| 06/26/1997 | WO1997009600A3 Method of isolating cells |
| 06/26/1997 | WO1997007225A3 High efficiency retroviral packaging system |
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | CA2246299A1 An expression system for anaerobic gene expression in higher plants |
| 06/26/1997 | CA2241371A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | CA2240938A1 Utrophin gene expression |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2239783A1 Host adaptation of retroviral vectors |
| 06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
| 06/25/1997 | EP0780469A1 Immortalized human skin cell lines and serum-free medium for the production thereof |
| 06/25/1997 | EP0779931A1 Methods for calcium phosphate transfection |
| 06/25/1997 | EP0779930A1 Methods and compositions for inhibiting production of replication competent virus |
| 06/25/1997 | EP0779928A1 Acetohydroacid synthase promoter for expression of introduced genes in plants |
| 06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 06/25/1997 | CN1152941A Genes for the synthesis of antipathogenic substances |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152939A Monoclonal antibodies which promote central nervous system remyelination |
| 06/25/1997 | CN1152938A Growth control for cells encapsulated within bioartificial organs |
| 06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/25/1997 | CN1152935A Papillomavirus vaccines |
| 06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |